Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
85,944,579
-
Shares change
-
+10,242,614
-
Total reported value, excl. options
-
$2,946,905,994
-
Value change
-
+$357,311,792
-
Put/Call ratio
-
1.14%
-
Number of buys
-
127
-
Number of sells
-
-61
-
Price
-
$34.31
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2020
219 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q2 2020.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85,944,579 shares
of 114,331,829 outstanding shares and own 75.17% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (12,629,737 shares), FMR LLC (6,337,023 shares), BlackRock Inc. (6,100,146 shares), VANGUARD GROUP INC (5,098,551 shares), JANUS HENDERSON GROUP PLC (3,659,394 shares), FARALLON CAPITAL MANAGEMENT LLC (3,500,000 shares), Johnson & Johnson Innovation - JJDC, Inc. (3,379,064 shares), CITADEL ADVISORS LLC (3,277,477 shares), STATE STREET CORP (3,101,641 shares), and Casdin Capital, LLC (3,050,000 shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.